BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 15, Issue 6
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (7004)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.
Item 
Count 
PDF102
WORD34
HTML4807
Figures (1-3)560
Tables (1-2)489
 Sum=5992
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse171
Download428
 Sum=599
Jun 27, 2023 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Zhang CY, Liu S, Yang M. Treatment of liver fibrosis: Past, current, and future. World J Hepatol 2023; 15(6): 755-774 [PMID: 37397931 DOI: 10.4254/wjh.v15.i6.755]
URL: https://www.wjgnet.com/1949-8454/full/v15/i6/755.htm
Number Citing Articles
1
Girish L. Gupte, Anshu Srivastava. Chronic Liver Disease in Children: From Diagnosis to Liver Transplantation. Indian Journal of Pediatrics 2024; 91(3): 260 doi: 10.1007/s12098-024-05030-3
2
Peng Ji, Yan Li, Zihan Wang, Siyu Jia, Xinyi Jiang, Hui Chen, Qun Wang. Advances in precision gene editing for liver fibrosis: From technology to therapeutic applications. Biomedicine & Pharmacotherapy 2024; 177: 117003 doi: 10.1016/j.biopha.2024.117003
3
Arndt Vogel, Robert C. Grant, Tim Meyer, Gonzalo Sapisochin, Grainne M. O’Kane, Anna Saborowski. Adjuvant and neoadjuvant therapies for hepatocellular carcinoma. Hepatology 2023;  doi: 10.1097/HEP.0000000000000726
4
Ming Yang, Chun-Ye Zhang. Interleukins in liver disease treatment. World Journal of Hepatology 2024; 16(2): 140-145 doi: 10.4254/wjh.v16.i2.140
5
Sayed H. Seif el-Din, Olfat A. Hammam, Shahira M. Ezzat, Samira Saleh, Marwa M. Safar, Walaa H. El-Maadawy, Naglaa M. El-Lakkany. Hydroxysafflor yellow A protects against thioacetamide-induced liver fibrosis in rats via suppressing proinflammatory/fibrogenic mediators and promoting hepatic stellate cell senescence and apoptosis. Asian Pacific Journal of Tropical Biomedicine 2023; 13(8): 348 doi: 10.4103/2221-1691.383689
6
Nidal Jaradat, Mohammed Hawash, Majid Sharifi-Rad, Ali Shakhshir, Shorooq Sobuh, Fatima Hussein, Linda Issa, Sondos Hamamrhe, Eman Al-Sheikh, Alaa Naser Ibrahim. Insights into free radicals scavenging, α-Amylase inhibition, cytotoxic and antifibrotic activities unveiled by Peganum harmala extracts. BMC Complementary Medicine and Therapies 2024; 24(1) doi: 10.1186/s12906-024-04602-2
7
A. V. Vasyutin, V. V. Tsukanov, N. E. Veselova, E. G. Gorchilova, J. L. Tonkikh, A. A. Savchenko, A. G. Borisov. Association of neutropenia and decreased neutrophil function with liver fibrosis in patients with Opisthorchis felineus invasion. Meditsinskiy sovet = Medical Council 2024; (15): 62 doi: 10.21518/ms2024-339
8
Tamer A. Addissouky, Majeed M. A. Ali, Ibrahim El Tantawy El Sayed, Yuliang Wang. Emerging advanced approaches for diagnosis and inhibition of liver fibrogenesis. The Egyptian Journal of Internal Medicine 2024; 36(1) doi: 10.1186/s43162-024-00283-y
9
Aneta Sokal-Dembowska, Sara Jarmakiewicz-Czaja, Katarzyna Ferenc, Rafał Filip. Can Nutraceuticals Support the Treatment of MASLD/MASH, and thus Affect the Process of Liver Fibrosis?. International Journal of Molecular Sciences 2024; 25(10): 5238 doi: 10.3390/ijms25105238
10
Devadoss J. Samuvel, John J. Lemasters, C. James Chou, Zhi Zhong. LP340, a novel histone deacetylase inhibitor, decreases liver injury and fibrosis in mice: role of oxidative stress and microRNA-23a. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1386238
11
Watunyoo Buakaew, Sucheewin Krobthong, Yodying Yingchutrakul, Pachuen Potup, Yordhathai Thongsri, Krai Daowtak, Antonio Ferrante, Kanchana Usuwanthim. Investigating the Antifibrotic Effects of β-Citronellol on a TGF-β1-Stimulated LX-2 Hepatic Stellate Cell Model. Biomolecules 2024; 14(7): 800 doi: 10.3390/biom14070800
12
Man Na, Xingbiao Yang, Yongkun Deng, Zhaoheng Yin, Mingwei Li. Endoplasmic reticulum stress in the pathogenesis of alcoholic liver disease. PeerJ 2023; 11: e16398 doi: 10.7717/peerj.16398
13
Galit Weinstein, Yochai Schonmann, Hanny Yeshua, Shira Zelber‐Sagi. The association between liver fibrosis score and incident dementia: A nationwide retrospective cohort study. Alzheimer's & Dementia 2024; 20(8): 5385 doi: 10.1002/alz.14033
14
Sara T. Elazab, Walter H. Hsu. Ferulic acid ameliorates concanavalin A-induced hepatic fibrosis in mice via suppressing TGF-β/smad signaling. Toxicology and Applied Pharmacology 2024; 492: 117099 doi: 10.1016/j.taap.2024.117099
15
Simona Cernea. NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay. Life 2024; 14(2): 272 doi: 10.3390/life14020272
16
Mohammadjavad Sotoudeheian. Galectin-3 and Severity of Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease. Protein & Peptide Letters 2024; 31(4): 290 doi: 10.2174/0109298665301698240404061300
17
Joey A. Muns, Erik Schooten, Rychon D. J. van Dasselaar, Yvet E. Noordman, Kevin Adamzek, Arthur C. Eibergen, Sebas D. Pronk, Sagel Cali, Niels J. Sijbrandi, Eugen Merkul, Sabrina Oliveira, Paul M.P. van Bergen en Henegouwen, R. Bart Takkenberg, Joanne Verheij, Stan F.J. van de Graaf, Bart A. Nijmeijer, Guus A.M.S. van Dongen. Preclinical targeting of liver fibrosis with a 89Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β. European Journal of Nuclear Medicine and Molecular Imaging 2024; 51(12): 3545 doi: 10.1007/s00259-024-06785-9
18
Pasquale Rapacciuolo, Claudia Finamore, Cristina Di Giorgio, Bianca Fiorillo, Carmen Massa, Ginevra Urbani, Silvia Marchianò, Martina Bordoni, Chiara Cassiano, Elva Morretta, Lucio Spinelli, Antonio Lupia, Federica Moraca, Michele Biagioli, Valentina Sepe, Maria Chiara Monti, Bruno Catalanotti, Stefano Fiorucci, Angela Zampella. Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis. Journal of Medicinal Chemistry 2024; 67(20): 18334 doi: 10.1021/acs.jmedchem.4c01651
19
Vasilii Slautin, Konstantin Konyshev, Ilya Gavrilov, Olga Beresneva, Irina Maklakova, Dmitry Grebnev. Fucoxanthin Enhances the Antifibrotic Potential of Placenta-derived Mesenchymal Stem Cells in a CCl4-induced Mouse Model of Liver. Current Stem Cell Research & Therapy 2024; 19(11): 1484 doi: 10.2174/011574888X279940231206100902
20
Feng Chen, Qianhui Li, Xiaomin Xu, Fei Wang. Non-invasive Diagnostic Indicators and Antiviral Treatment Efficacy in CHB Patients with Different Liver Histopathological Degrees. Hepatitis Monthly 2024; 24(1) doi: 10.5812/hepatmon-147016
21
Wiebke‐Felicitas Nierath, Emily Leitner, Sabrina Reimann, Rico Schwarz, Burkhard Hinz, André Bleich, Brigitte Vollmar, Dietmar Zechner. GSK805 inhibits alpha‐smooth muscle expression and modulates liver inflammation without impairing the well‐being of mice. The FASEB Journal 2024; 38(16) doi: 10.1096/fj.202400733R
22
Daisuke Taguchi, Yohei Shirakami, Hiroyasu Sakai, Toshihide Maeda, Takao Miwa, Masaya Kubota, Kenji Imai, Takashi Ibuka, Masahito Shimizu. High-Fat Diet Delays Liver Fibrosis Recovery and Promotes Hepatocarcinogenesis in Rat Liver Cirrhosis Model. Nutrients 2024; 16(15): 2506 doi: 10.3390/nu16152506
23
Xiao-Ling Wang, Meng Yang, Ying Wang. Roles of transforming growth factor-β signaling in liver disease. World Journal of Hepatology 2024; 16(7): 973-979 doi: 10.4254/wjh.v16.i7.973
24
Shradha P Kakde, Maham Mushtaq, Maryyam Liaqat, Husnain Ali, Muhammad Muaz Mushtaq, Muhammad Asad Sarwer, Sami Ullah, Muhammad Wali Hassan, Asma Khalid, Syed Faqeer Hussain Bokhari. Emerging Therapies for Non-Alcoholic Steatohepatitis (NASH): A Comprehensive Review of Pharmacological and Non-Pharmacological Approaches. Cureus 2024;  doi: 10.7759/cureus.69129
25
Vasudevan Sekar, Venkateish VP, Vani Vijay, Annapoorna BR, Nivya Vijayan, Madan Kumar Perumal. Inhibition of hepatic stellate cell activation by nutraceuticals: an emphasis on mechanisms of action. Journal of Food Science and Technology 2024; 61(11): 2046 doi: 10.1007/s13197-024-06002-3
26
Xiaoxin Liu, Ninglin Xia, Qinwei Yu, Ming Jin, Zifan Wang, Xue Fan, Wen Zhao, Anqin Li, Zhenzhou Jiang, Luyong Zhang. Silybin Meglumine Mitigates CCl4-Induced Liver Fibrosis and Bile Acid Metabolism Alterations. Metabolites 2024; 14(10): 556 doi: 10.3390/metabo14100556
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345